Full Text of HB1553 94th General Assembly
HB1553 94TH GENERAL ASSEMBLY
|
|
|
94TH GENERAL ASSEMBLY
State of Illinois
2005 and 2006 HB1553
Introduced 2/10/2005, by Rep. Karen May SYNOPSIS AS INTRODUCED: |
|
410 ILCS 50/2.06 new |
|
410 ILCS 50/3.1 |
from Ch. 111 1/2, par. 5403.1 |
|
Amends the Medical Patient Rights Act. Provides that any patient who is the subject of a research program, clinical trial or an experimental procedure shall be provided information regarding the results of the research, clinical trial or experimental procedure. Defines "clinical trial".
|
| |
|
|
A BILL FOR
|
|
|
|
|
HB1553 |
|
LRB094 06737 RXD 36836 b |
|
| 1 |
| AN ACT concerning health.
| 2 |
| Be it enacted by the People of the State of Illinois,
| 3 |
| represented in the General Assembly:
| 4 |
| Section 5. The Medical Patient Rights Act is amended by | 5 |
| changing Section 3.1 and by adding Section 2.06 as follows: | 6 |
| (410 ILCS 50/2.06 new) | 7 |
| Sec. 2.06. "Clinical trial", "clinical studies", or | 8 |
| "clinical research" means a research study using human subjects | 9 |
| intended to answer specific health questions, including | 10 |
| studies intended to find treatments that work in people and | 11 |
| ways to improve health, interventional trials that determine | 12 |
| whether experimental treatments or new ways of using known | 13 |
| therapies are safe and effective under controlled | 14 |
| environments, and observational trials that address health | 15 |
| issues in large groups of people or populations in natural | 16 |
| settings.
| 17 |
| (410 ILCS 50/3.1) (from Ch. 111 1/2, par. 5403.1)
| 18 |
| Sec. 3.1. (a) Any patient who is the subject of a research | 19 |
| program , clinical trial or
an experimental procedure, as | 20 |
| defined under the rules and regulations of
the Hospital | 21 |
| Licensing Act, or as defined by the National Institutes of | 22 |
| Health, shall have, at a minimum, the right to receive
an | 23 |
| explanation of the nature and possible consequences of such | 24 |
| research , clinical trial or
experiment before the research or | 25 |
| experiment is conducted, and to consent
to or reject it.
| 26 |
| (b) No health care provider
physician may conduct any | 27 |
| research program , clinical trial or experimental
procedure on a | 28 |
| patient without the prior informed consent of the patient
or, | 29 |
| if the patient is unable to consent, the patient's guardian, | 30 |
| spouse,
parent, or authorized agent.
| 31 |
| (c) This Section shall not apply to any research program , |
|
|
|
HB1553 |
- 2 - |
LRB094 06737 RXD 36836 b |
|
| 1 |
| clinical trial or medical
experimental procedure for patients | 2 |
| subject to a life-threatening emergency
that is conducted in | 3 |
| accordance with Part 50 of Title 21 of, and Part 46 of
Title 45 | 4 |
| of, the Code of Federal Regulations.
| 5 |
| (d) Any patient who is the subject of a research program, | 6 |
| clinical trial or an experimental procedure shall be provided | 7 |
| information regarding the results of the research, clinical | 8 |
| trial or experimental procedure, which must be provided | 9 |
| directly to the subject or by written notice of the formal | 10 |
| reference to the report of the results that may be accessed by | 11 |
| the subject, including, but not limited to, internet website | 12 |
| information available through the National Institutes of | 13 |
| Health.
| 14 |
| (Source: P.A. 90-36, eff. 6-27-97.)
|
|